From Psilocybin to MDMA: Researchers are in the throes of a psychedelic revival
Those who reported a “mystical experience” had the most success in breaking their addiction.
Griffiths’s lab pressed ahead with their work in a 2014 study on the possibility of treating nicotine addiction with psilocybin, the psychedelic component of “magic mushrooms.” Participants had three psilocybin sessions and three cognitive-behavioral therapy sessions to diminish cravings. Eighty percent of those who received the psilocybin treatments abstained from nicotine for over six months, while less than 7 percent of those who received traditional nicotine-replacement therapy were successful for more than six months. Those who reported a “mystical experience” had the most success in breaking their addiction.
Original Article (Mint Press News):
From Psilocybin To MDMA: Researchers Are In The Throes Of A Psychedelic Revival
Artwork Fair Use: Lindsay Fox